Yorvipath User Reviews & Ratings
Yorvipath has an average rating of 7.5 out of 10 from a total of 2 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Hypoparathyroidism | 2 reviews for Hypoparathyroidism | 16 medications |
- Ano...
- Taken for 1 to 6 months
- June 1, 2025
For Hypoparathyroidism "Daily headaches since starting the medication. I have considered stopping the medication if it doesn't improve."
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Yorvipath (palopegteriparatide)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: parathyroid hormone and analogs
For Hypoparathyroidism "I started Yorvipath a month ago. Since then, my kidney function has improved in my first 4 blood tests. I’ve reduced my calcium intake by 60% and stopped all vitamin D supplements. I was hopeful I would have a great result, but this was much faster than expected. I had a temporary backache for a few days. It resolved quickly. I had irritation at the injection site. I switched to the thighs from the stomach and have much less irritation. I’m hoping my next DEXA scan shows improvement in my bones. I’m very satisfied so far."